ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 196 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $5,000 | +66.7% | 300 | +50.0% | 0.00% | 0.0% |
Q4 2017 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $2,000 | -33.3% | 200 | -33.3% | 0.00% | 0.0% |
Q2 2017 | $3,000 | -25.0% | 300 | -40.0% | 0.00% | 0.0% |
Q1 2017 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $2,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |